SARS-CoV-2 mRNA mRNA adjuvant mixture method for SARS-CoV-2

摘要

The present invention relates to an mRNA adjuvant for the prevention of SARS-CoV-2 (corona virus), and an object of the present invention is to prevent the above antigens as a vaccine against coronavirus. The idea consists of a complete Freund's antigen adjuvant (CFA) and an incomplete Freund's antigen adjuvant (IFA), an optimized translation and stability mRNA, an mRNA carrier, and cationic lipid nanoparticles. Compared to vaccines, it has more improved effects in terms of efficiency and stability.